Reply to the letter regarding the article entitled “A combination of TMP/SMX with linezolid is useful for Actinomycotic mycetoma: A precis on the existential data and the rationale of combination therapy”

Sir,

We thank the correspondents¹ for their interest in our article.² We apologise for missing their article in our review of literature. While we agree with their comments, we could not plan treatment for our patient based on drug sensitivity as the organism did not grow in culture. We used empirical monotherapy with linezolid because she had failed combination treatment with amikacin, cotrimoxazole and doxycycline. The patient has not shown any recurrence after two years of follow-up.